vs

Side-by-side financial comparison of NGL Energy Partners LP (NGL) and DENTSPLY SIRONA Inc. (XRAY). Click either name above to swap in a different company.

DENTSPLY SIRONA Inc. is the larger business by last-quarter revenue ($961.0M vs $909.8M, roughly 1.1× NGL Energy Partners LP). NGL Energy Partners LP runs the higher net margin — 5.2% vs -15.2%, a 20.4% gap on every dollar of revenue. On growth, DENTSPLY SIRONA Inc. posted the faster year-over-year revenue change (6.2% vs -41.3%). DENTSPLY SIRONA Inc. produced more free cash flow last quarter ($60.0M vs $45.7M). Over the past eight quarters, DENTSPLY SIRONA Inc.'s revenue compounded faster (0.4% CAGR vs -6.4%).

NGL Energy Partners LP is a U.S.-based midstream energy services firm. It offers transportation, storage, and logistics solutions for crude oil, natural gas liquids, and renewable fuels, plus water management services for upstream energy producers, operating primarily across North American markets.

Dentsply Sirona Inc. is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries. It has factories in 21 countries. The present company is largely the result of a merger in 1993 in which Gendex Corporation acquired Dentsply International Inc. for $590 million.

NGL vs XRAY — Head-to-Head

Bigger by revenue
XRAY
XRAY
1.1× larger
XRAY
$961.0M
$909.8M
NGL
Growing faster (revenue YoY)
XRAY
XRAY
+47.5% gap
XRAY
6.2%
-41.3%
NGL
Higher net margin
NGL
NGL
20.4% more per $
NGL
5.2%
-15.2%
XRAY
More free cash flow
XRAY
XRAY
$14.3M more FCF
XRAY
$60.0M
$45.7M
NGL
Faster 2-yr revenue CAGR
XRAY
XRAY
Annualised
XRAY
0.4%
-6.4%
NGL

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
NGL
NGL
XRAY
XRAY
Revenue
$909.8M
$961.0M
Net Profit
$47.2M
$-146.0M
Gross Margin
29.0%
46.1%
Operating Margin
12.1%
-14.5%
Net Margin
5.2%
-15.2%
Revenue YoY
-41.3%
6.2%
Net Profit YoY
249.3%
66.0%
EPS (diluted)
$-0.74

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NGL
NGL
XRAY
XRAY
Q4 25
$909.8M
$961.0M
Q3 25
$674.7M
$904.0M
Q2 25
$622.2M
$936.0M
Q1 25
$971.1M
$879.0M
Q4 24
$982.4M
$905.0M
Q3 24
$756.5M
$951.0M
Q2 24
$759.2M
$984.0M
Q1 24
$1.0B
$953.0M
Net Profit
NGL
NGL
XRAY
XRAY
Q4 25
$47.2M
$-146.0M
Q3 25
$29.3M
$-427.0M
Q2 25
$68.9M
$-45.0M
Q1 25
$13.7M
$20.0M
Q4 24
$13.5M
$-430.0M
Q3 24
$2.5M
$-494.0M
Q2 24
$9.7M
$-4.0M
Q1 24
$-236.8M
$18.0M
Gross Margin
NGL
NGL
XRAY
XRAY
Q4 25
29.0%
46.1%
Q3 25
37.6%
48.8%
Q2 25
38.5%
52.4%
Q1 25
26.9%
53.0%
Q4 24
25.1%
49.3%
Q3 24
30.9%
52.1%
Q2 24
29.0%
51.9%
Q1 24
21.8%
53.1%
Operating Margin
NGL
NGL
XRAY
XRAY
Q4 25
12.1%
-14.5%
Q3 25
14.0%
-24.1%
Q2 25
15.7%
-13.7%
Q1 25
8.4%
7.2%
Q4 24
8.6%
-56.2%
Q3 24
10.8%
-48.6%
Q2 24
10.8%
5.1%
Q1 24
-9.4%
4.4%
Net Margin
NGL
NGL
XRAY
XRAY
Q4 25
5.2%
-15.2%
Q3 25
4.3%
-47.2%
Q2 25
11.1%
-4.8%
Q1 25
1.4%
2.3%
Q4 24
1.4%
-47.5%
Q3 24
0.3%
-51.9%
Q2 24
1.3%
-0.4%
Q1 24
-22.8%
1.9%
EPS (diluted)
NGL
NGL
XRAY
XRAY
Q4 25
$-0.74
Q3 25
$-2.14
Q2 25
$-0.22
Q1 25
$0.10
Q4 24
$-2.09
Q3 24
$-2.46
Q2 24
$-0.02
Q1 24
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NGL
NGL
XRAY
XRAY
Cash + ST InvestmentsLiquidity on hand
$6.5M
$326.0M
Total DebtLower is stronger
$2.9B
$2.3B
Stockholders' EquityBook value
$1.3B
Total Assets
$4.4B
$5.4B
Debt / EquityLower = less leverage
1.70×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NGL
NGL
XRAY
XRAY
Q4 25
$6.5M
$326.0M
Q3 25
$8.7M
$363.0M
Q2 25
$5.4M
$359.0M
Q1 25
$13.5M
$398.0M
Q4 24
$5.7M
$272.0M
Q3 24
$4.5M
$296.0M
Q2 24
$5.3M
$279.0M
Q1 24
$38.9M
$291.0M
Total Debt
NGL
NGL
XRAY
XRAY
Q4 25
$2.9B
$2.3B
Q3 25
$2.9B
Q2 25
$2.9B
Q1 25
$3.0B
Q4 24
$3.1B
$1.7B
Q3 24
$3.1B
Q2 24
$3.0B
Q1 24
$2.9B
Stockholders' Equity
NGL
NGL
XRAY
XRAY
Q4 25
$1.3B
Q3 25
$1.5B
Q2 25
$2.0B
Q1 25
$2.0B
Q4 24
$1.9B
Q3 24
$2.5B
Q2 24
$3.1B
Q1 24
$3.3B
Total Assets
NGL
NGL
XRAY
XRAY
Q4 25
$4.4B
$5.4B
Q3 25
$4.3B
$5.7B
Q2 25
$4.2B
$6.1B
Q1 25
$4.6B
$6.0B
Q4 24
$4.8B
$5.8B
Q3 24
$4.9B
$6.6B
Q2 24
$4.8B
$6.9B
Q1 24
$5.0B
$7.1B
Debt / Equity
NGL
NGL
XRAY
XRAY
Q4 25
1.70×
Q3 25
Q2 25
Q1 25
Q4 24
0.90×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NGL
NGL
XRAY
XRAY
Operating Cash FlowLast quarter
$182.3M
$101.0M
Free Cash FlowOCF − Capex
$45.7M
$60.0M
FCF MarginFCF / Revenue
5.0%
6.2%
Capex IntensityCapex / Revenue
15.0%
4.3%
Cash ConversionOCF / Net Profit
3.86×
TTM Free Cash FlowTrailing 4 quarters
$126.7M
$104.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NGL
NGL
XRAY
XRAY
Q4 25
$182.3M
$101.0M
Q3 25
$40.5M
$79.0M
Q2 25
$33.2M
$48.0M
Q1 25
$155.0M
$7.0M
Q4 24
$153.8M
$87.0M
Q3 24
$6.7M
$141.0M
Q2 24
$-18.1M
$208.0M
Q1 24
$152.2M
$25.0M
Free Cash Flow
NGL
NGL
XRAY
XRAY
Q4 25
$45.7M
$60.0M
Q3 25
$9.5M
$40.0M
Q2 25
$11.1M
$16.0M
Q1 25
$60.4M
$-12.0M
Q4 24
$152.1M
$36.0M
Q3 24
$-82.9M
$98.0M
Q2 24
$-78.0M
$156.0M
Q1 24
$119.8M
$-9.0M
FCF Margin
NGL
NGL
XRAY
XRAY
Q4 25
5.0%
6.2%
Q3 25
1.4%
4.4%
Q2 25
1.8%
1.7%
Q1 25
6.2%
-1.4%
Q4 24
15.5%
4.0%
Q3 24
-11.0%
10.3%
Q2 24
-10.3%
15.9%
Q1 24
11.5%
-0.9%
Capex Intensity
NGL
NGL
XRAY
XRAY
Q4 25
15.0%
4.3%
Q3 25
4.6%
4.3%
Q2 25
3.6%
3.4%
Q1 25
9.7%
2.2%
Q4 24
0.2%
5.6%
Q3 24
11.8%
4.5%
Q2 24
7.9%
5.3%
Q1 24
3.1%
3.6%
Cash Conversion
NGL
NGL
XRAY
XRAY
Q4 25
3.86×
Q3 25
1.38×
Q2 25
0.48×
Q1 25
11.29×
0.35×
Q4 24
11.39×
Q3 24
2.74×
Q2 24
-1.87×
Q1 24
1.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NGL
NGL

Water Solutions Segment$208.6M23%
Services$193.3M21%
Butane$192.5M21%
Service Fees$182.8M20%
Public Utilities Inventory Propane$93.9M10%
Crude Oil$23.3M3%
Crude Oil Transportation And Other$6.5M1%
Liquids Logistics Segment$2.5M0%
Crude Oil Logistics Segment$1.2M0%

XRAY
XRAY

Essential Dental Solutions$372.0M39%
Equipment And Instruments$160.0M17%
Implants And Prosthetics$150.0M16%
CADCAM$139.0M14%
Wellspect Healthcare$88.0M9%
Orthodontics$52.0M5%

Related Comparisons